About us
Eye3 is developing a next-generation point of care screening device for detecting alcohol and recreational drugs.
In partnership with McMaster University, Eye3’s objective is to conduct performance and validation studies to support regulatory submissions and commercialization.
Program engagement
Eye3
Leadership:
Kate Riley
CEO
David Wilson
Founder
Stage:
- Idea Stage
Sector:
- Life Sciences
Subsector:
- Diagnostic Tool